Fortive Corp

FTV · NYSE · Technology / Scientific & Technical Instruments

67.92USD+0.07 (+0.10%)

Price History

Full chart

Market Stats

Previous Close67.85

Open68.27

Day Range67.29 – 68.27

52-Week Range47.50 – 64.48

Volume1.83M

Market Cap16.74B

P/E (TTM)29.33

Forward P/E17.27

EPS1.89

Dividend Yield0.51%

Beta0.97

50-Day Avg59.14

200-Day Avg58.24

About

Fortive Corporation designs, develops, manufactures, and markets products, software, and services in the United States, China, and internationally. It operates through Intelligent Operating Solutions and Advanced Healthcare Solutions segments. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including maintenance, repair, measurement and condition monitoring, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, and SERVICECHANNEL brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, FLUKE BIOMEDICAL, LANDAUER, and PROVATION brand names. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.

Company Details

SectorTechnology
IndustryScientific & Technical Instruments
CEOMr. Olumide O. Soroye J.D.
Employees10.00K
Headquarters6920 Seaway Boulevard, Everett, WA, United States, 98203, USA
Websitehttps://www.fortive.com

Leadership

Mr. Olumide O. Soroye J.D.President, CEO & Director · b. 1973
Mr. Mark D. Okerstrom J.D.Senior VP & CFO · b. 1973
Mr. Peter C. Underwood J.D.Senior VP & Chief Legal Officer · b. 1970
Mr. Christopher M. MulhallChief Accounting Officer · b. 1974
Mr. Victor P. Fetter IIISenior VP & Chief Technology and Business System Officer · b. 1969
Ms. Amee DesjourdySenior VP & Chief People Officer · b. 1973
Mr. Parker BurkePresident of Fluke & Group President of Connected Reliability Group (CRG)
Mr. Arul ElumalaiPresident of Gordian and Group President of Facilities & Asset Lifecycle (FAL) Group
Mr. Chad RohrerPresident of ASP & Group President of Infection Prevention Group (IPG)
Mr. Ankush KaulPresident of Provation & Group President of Healthcare Productivity and Quality (HPQ) Group

Financials

Income Statement

Currency: USD	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	5.79B	5.96B	6.34B	6.18B	6.22B	5.76B	6.45B	4.56B	4.63B	5.25B	5.83B	6.07B	6.23B	5.14B
Growth (%)	-	+3.05%	+6.29%	-2.50%	+0.74%	-7.52%	+12.10%	-29.27%	+1.54%	+13.38%	+10.87%	+4.11%	+2.75%	-17.48%
Cost of Revenue	3.00B	3.09B	3.28B	3.18B	3.18B	2.83B	3.13B	2.07B	2.02B	2.24B	2.46B	2.47B	2.50B	2.01B
Gross Profit	2.78B	2.87B	3.06B	3.00B	3.04B	2.92B	3.32B	2.50B	2.62B	3.01B	3.36B	3.59B	3.73B	3.13B
Gross Margin	48.11%	48.21%	48.21%	48.57%	48.86%	50.79%	51.50%	54.71%	56.46%	57.28%	57.73%	59.26%	59.87%	60.96%
Operating Expense	1.61B	1.70B	1.78B	1.71B	1.77B	1.76B	2.14B	1.97B	1.97B	2.18B	2.36B	2.46B	2.55B	2.23B
Operating Income	1.17B	1.17B	1.27B	1.29B	1.27B	1.16B	1.19B	529.30M	650.20M	831.50M	1.01B	1.13B	1.18B	908.90M
Operating Margin	20.23%	19.65%	20.09%	20.94%	20.37%	20.18%	18.37%	11.60%	14.03%	15.82%	17.26%	18.69%	18.88%	17.67%
EBITDA	1.27B	1.30B	1.46B	1.45B	1.42B	1.32B	1.44B	820.80M	2.04B	1.18B	1.44B	1.13B	1.67B	1.20B
EBITDA Margin	22.00%	21.85%	22.99%	23.41%	22.85%	22.94%	22.26%	17.98%	44.02%	22.38%	24.67%	18.69%	26.74%	23.34%
Net Income	763.70M	830.90M	883.40M	863.80M	872.30M	1.04B	2.91B	738.90M	1.61B	608.40M	755.20M	865.80M	832.90M	579.20M
Net Income Margin	13.20%	13.94%	13.94%	13.98%	14.01%	18.15%	45.16%	16.19%	34.81%	11.58%	12.96%	14.27%	13.37%	11.26%
R&D	352.70M	378.30M	387.60M	377.70M	384.80M	369.30M	414.30M	320.30M	320.70M	354.80M	401.50M	397.80M	414.00M	342.30M
R&D as % of Total Revenue	6.10%	6.35%	6.12%	6.11%	6.18%	6.42%	6.42%	7.02%	6.92%	6.75%	6.89%	6.56%	6.64%	6.66%
Interest Expense	0	0	0	0	49.00M	88.70M	97.00M	142.60M	148.50M	103.20M	98.30M	123.50M	152.80M	120.50M
Interest Expense % of Total Revenue	0.00%	0.00%	0.00%	0.00%	0.79%	1.54%	1.50%	3.12%	3.20%	1.96%	1.69%	2.04%	2.45%	2.34%

Balance Sheet

Currency: USD	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	-	7.24B	7.36B	7.21B	8.19B	10.50B	12.91B	17.44B	16.05B	16.47B	15.89B	16.91B	17.02B	11.74B
Total Liabilities	-	2.12B	2.12B	2.03B	5.50B	6.69B	6.29B	10.04B	7.08B	6.95B	6.20B	6.59B	6.82B	5.28B
Total Equity	-	5.12B	5.23B	5.18B	2.69B	3.81B	6.60B	7.39B	8.96B	9.51B	9.68B	10.32B	10.19B	6.45B
Cash	-	-	-	803.20M	803.20M	962.10M	1.18B	1.21B	1.82B	819.30M	709.20M	1.89B	813.30M	375.50M
Total Debt	-	-	-	-	3.77B	4.55B	3.43B	6.50B	4.43B	4.14B	3.42B	3.81B	3.88B	3.21B
Net Debt	-	-	-	-	2.55B	3.09B	2.25B	5.30B	2.61B	3.32B	2.71B	1.92B	3.06B	2.83B

Cash Flow

Currency: USD	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	944.00M	1.03B	946.70M	1.01B	1.14B	1.18B	1.34B	1.27B	1.44B	961.10M	1.30B	1.35B	1.53B	1.08B
Investing Cash Flow	-348.40M	-511.40M	-291.10M	-174.10M	-310.80M	-1.67B	-1.97B	-4.05B	-148.40M	-2.62B	-102.50M	-195.40M	-1.80B	-135.40M
Financing Cash Flow	-595.60M	-518.80M	-655.60M	-834.90M	3.80M	599.70M	879.10M	2.80B	-696.10M	652.00M	-1.27B	32.30M	-792.70M	-1.39B
Capital Expenditure	69.60M	81.10M	102.60M	120.10M	129.60M	136.10M	112.30M	112.50M	75.70M	50.00M	95.80M	107.80M	120.40M	105.10M
Free Cash Flow	874.40M	949.10M	844.10M	888.90M	1.01B	1.04B	1.23B	1.16B	1.36B	911.10M	1.21B	1.25B	1.41B	978.10M
Dividends Paid	-	-	48.40M	48.40M	3.05B	97.20M	131.50M	162.80M	163.40M	132.20M	99.50M	102.00M	111.20M	92.20M
FCF to OCF	92.63%	92.13%	89.16%	88.10%	88.60%	88.43%	91.65%	91.15%	94.73%	94.80%	92.65%	92.04%	92.11%	90.30%
Dividend Paid to FCF	-	-	5.73%	5.44%	302.63%	9.34%	10.67%	14.05%	12.01%	14.51%	8.24%	8.19%	7.91%	9.43%

Earnings

Report Date	Jun 15, 2016	Aug 2, 2016	Oct 27, 2016	Feb 7, 2017	Apr 27, 2017	Jul 27, 2017	Oct 26, 2017	Feb 8, 2018	Apr 26, 2018	Jul 26, 2018	Oct 25, 2018	Feb 7, 2019	Apr 25, 2019	Jul 25, 2019	Oct 24, 2019	Feb 6, 2020	Apr 30, 2020	Jul 28, 2020	Oct 27, 2020	Feb 4, 2021	Apr 29, 2021	Jul 29, 2021	Oct 28, 2021	Feb 3, 2022	Apr 28, 2022	Jul 28, 2022	Oct 26, 2022	Feb 1, 2023	Apr 26, 2023	Jul 26, 2023	Oct 25, 2023	Jan 31, 2024	Apr 24, 2024	Jul 24, 2024	Oct 30, 2024	Feb 7, 2025	May 1, 2025	Jul 30, 2025	Oct 29, 2025	Feb 4, 2026	Apr 30, 2026	Jul 29, 2026	Nov 4, 2026
EPS Estimate	0.00	0.61	0.59	0.67	0.57	0.69	0.73	0.78	0.75	0.89	0.86	0.85	0.69	0.89	0.87	0.97	0.69	0.58	0.86	0.62	0.60	0.60	0.65	0.78	0.68	0.72	0.76	0.84	0.73	0.81	0.85	0.94	0.79	0.92	0.93	1.12	0.85	0.59	0.57	0.84	0.64	0.71	0.70
EPS Actual	0.48	0.64	0.67	0.68	0.60	0.71	0.77	0.82	0.78	0.91	0.86	0.91	0.69	0.90	0.87	1.03	0.74	0.68	0.94	0.70	0.63	0.66	0.66	0.79	0.70	0.78	0.79	0.88	0.75	0.85	0.85	0.98	0.83	0.93	0.97	1.17	0.85	0.58	0.68	0.90	0.70	0.74	-
Surprise	-	4.92%	13.56%	1.49%	5.26%	2.90%	5.48%	5.13%	4.00%	2.25%	0.00%	7.06%	0.00%	1.12%	0.00%	6.19%	7.25%	17.24%	9.30%	12.90%	5.00%	10.00%	1.54%	1.28%	2.94%	8.33%	3.95%	4.76%	2.74%	4.94%	0.00%	4.26%	5.06%	1.09%	4.30%	4.46%	0.00%	-1.69%	19.30%	7.14%	9.38%	4.23%	-
Timing	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	-

Key Statistics & Ratios

Market Cap16.74B

Enterprise Value20.13B

Trailing P/E29.33

Forward P/E17.27

PEG Ratio1.29

Price / Sales3.88

Price / Book2.80

EPS1.89

Book Value20.03

Revenue (TTM)4.32B

Gross Profit (TTM)2.73B

EBITDA1.23B

Profit Margin12.38%

Operating Margin19.14%

Return on Equity7.32%

Return on Assets3.30%

Shares Outstanding302.02M

Shares Float280.95M

Beta0.97

Dividend Yield0.51%

Dividend Rate0.28

Payout Ratio8.28%

Analyst Ratings

Hold

Based on 17 analystsTarget 64.31

Strong Buy
3
Buy
1
Hold
11
Sell
1
Strong Sell
1

Ownership Breakdown

Institutions: 112.49%
Insiders: 0.41%
Retail / Other: 0.00%

Top Institutional Holders

Dodge & Cox
43.98M14.56%
BlackRock Inc
31.63M10.47%
T. Rowe Price Associates, Inc.
23.72M7.86%
Viking Global Investors LP
22.48M7.44%
Vanguard Capital Management, LLC
20.21M6.69%
State Street Corp
13.61M4.51%
Vanguard Portfolio Management, LLC
13.15M4.36%
Flossbach von Storch AG
12.11M4.01%
Geode Capital Management, LLC
9.25M3.06%
Barrow Hanley Mewhinney & Strauss LLC
8.64M2.86%
Amvescap Plc.
7.76M2.57%
NORGES BANK
7.34M2.43%
Manufacturers Life Insurance Co
5.55M1.84%
UBS Group AG
4.39M1.45%
UBS Asset Mgmt Americas Inc
4.21M1.39%
Nordea Investment Mgmt Bank Demark A/s
4.17M1.38%

Top Fund Holders

Dodge & Cox Stock I
28.21M9.34%
Vanguard MStar Total Stk Mkt Idx Invest
9.68M3.21%
Vanguard 500 Index Investor
8.10M2.68%
FvS SICAV Multiple Opportunities F
6.70M2.22%

Dividends

20263×

0.07Sep 4, 20260.06Jun 22, 20260.06Mar 13, 2026

20255×

0.06Nov 28, 20250.06Sep 12, 20250.05Sep 8, 20250.06May 30, 20250.06Feb 28, 2025

20244×

0.06Nov 29, 20240.06Sep 13, 20240.06May 31, 20240.06Feb 22, 2024

20234×

0.06Nov 22, 20230.05Aug 31, 20230.05May 25, 20230.05Feb 23, 2023

20224×

0.05Nov 29, 20220.05Aug 30, 20220.05May 26, 20220.05Feb 24, 2022

20214×

0.05Nov 24, 20210.05Sep 9, 20210.05May 27, 20210.05Feb 25, 2021

Stock Splits

Jun 30, 20251327:1000
Oct 9, 20201195:1000